Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Fennec Pharmaceuticals Inc. Income Statement Banner

Fennec Pharmaceuticals Inc. Income Statement

FENC Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.0000.0000.0000.0000.0000.000170.000K0.0001.535M21.642M
Cost of Revenue
0.0000.0000.0000.0000.0000.0000.0000.00086.000K1.282M
Gross Profit
0.0000.0000.0000.0000.0000.000170.000K0.0001.449M20.360M
Operating Expense
2.877M1.890M2.871M6.951M10.409M13.009M18.055M17.223M24.038M33.365M
Operating Income
-2.877m-1.890m-2.871m-6.951m-10.409m-13.009m-17.885m-17.223m-22.589m-13.005m
Other Income Expense
0.0000.000-14.000k-8.000k6.000K-17.000k-9.000k0.0000.0000.000
Total Other Income Expense
699.000K1.228M74.000K-142.000k173.000K234.000K-224.000k-123.000k-1.125m-3.334m
Pretax Income
-2.176m-659.000k-2.789m-7.046m-9.888m-12.775m-18.109m-17.346m-23.714m-16.339m
Tax Provision
-2.000k-3.000k-8.000k-47.000k-348.000k-315.000k-187.000k110.000K1.125M1.000
Net Income
-2.176m-659.000k-2.789m-7.046m-9.888m-12.460m-17.922m-17.456m-24.839m-16.339m
Basic EPS
-0.220-0.061-0.220-0.470-0.520-0.630-0.760-0.670-0.950-0.610
Diluted EPS
-0.220-0.061-0.220-0.470-0.520-0.630-0.760-0.670-0.950-0.610
Basic Average Shares
9.871M10.827M12.677M14.991M18.942M19.896M23.704M26.006M26.275M26.574M
Diluted Average Shares
9.871M10.827M12.765M15.014M19.015M19.896M23.704M26.006M26.275M26.574M
Total Expenses
2.877M1.890M2.871M6.951M10.409M13.009M18.055M17.223M24.124M34.647M
Interest Income
2.000K3.000K0.0000.0000.000322.323K87.000K54.000K195.000K441.000K
Interest Expense
2.000K0.0000.0000.0000.0000.0009.000K126.000K978.000K3.394M
EBITDA
-3.576m-3.118m-2.959m-6.817m-10.576m-13.009m-17.985m-17.185m-22.543m-13.005m
Depreciation & Amortization
-699.000k-1.228m2.871M6.951M10.409M13.009M402.000K17.223M149.000K287.000K